• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型多发性硬化症的认知表现:处于风险中还是受损?

Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?

机构信息

Department of Human Neurosciences, Sapienza University, Rome, Italy,

Multiple Sclerosis Center, Sapienza University, Rome, Italy,

出版信息

Dement Geriatr Cogn Disord. 2020;49(6):539-543. doi: 10.1159/000514674. Epub 2021 Mar 18.

DOI:10.1159/000514674
PMID:33735893
Abstract

INTRODUCTION

Since cognitive impairment (CI) occurs on average in 45% of multiple sclerosis (MS) patients, the early detection of patients "at risk" of CI is important in order to promptly apply preventive strategies. The aim of the present study was to investigate the prevalence and risk factors for CI in MS patients using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) as a screening test.

METHODS

During the 1-year period, CI was evaluated in 82 consecutives mild relapsing-remitting MS (EDSS ≤ 3.5) patients. Patients with 1 altered BICAMS test were defined "at risk." Both "at risk" and CI patients underwent an extensive neuropsychological battery.

RESULTS

We found that: (i) 23% had CI, (ii), 25% were "at risk" of CI, and (iii) 76% of the "at risk" patients were already impaired at the NP assessment. In particular, the Symbol Digit Modalities Test was the most compromised (70% of "at risk" and 79% of CI patients). Patients with CI had more frequently an EDSS ≥ 2.5 (p = 0.05), lower education (p = 0.05), and relapses in the last 12 months (p = 0.03).

CONCLUSIONS

CI is a significant issue in MS and integration of a screening test, such as the SDMT, into routine clinical practice could be of worth to identify "at risk" patients and to promote an early therapeutic intervention.

摘要

简介

由于认知障碍(CI)平均出现在 45%的多发性硬化症(MS)患者中,因此早期发现有 CI 风险的患者对于及时应用预防策略非常重要。本研究旨在使用多发性硬化症简短认知评估(BICAMS)作为筛查测试,调查 MS 患者 CI 的患病率和危险因素。

方法

在 1 年期间,对 82 例连续轻度复发缓解型 MS(EDSS≤3.5)患者进行了 CI 评估。将 1 项 BICAMS 测试异常的患者定义为“有风险”。对“有风险”和 CI 患者均进行了广泛的神经心理学测试。

结果

我们发现:(i)23%的患者有 CI;(ii)25%的患者有 CI 风险;(iii)76%的“有风险”患者在 NP 评估中已经受损。特别是,符号数字模态测试受到的影响最大(70%的“有风险”患者和 79%的 CI 患者)。CI 患者的 EDSS≥2.5 的更频繁(p=0.05)、受教育程度较低(p=0.05),且在过去 12 个月中发生了更多的复发(p=0.03)。

结论

CI 是 MS 的一个重要问题,将筛查测试(如 SDMT)纳入常规临床实践可能有助于识别“有风险”患者,并促进早期治疗干预。

相似文献

1
Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?复发缓解型多发性硬化症的认知表现:处于风险中还是受损?
Dement Geriatr Cogn Disord. 2020;49(6):539-543. doi: 10.1159/000514674. Epub 2021 Mar 18.
2
Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.简要国际认知评估多发性硬化症(BICAMS):丹麦在多发性硬化症早期阶段的敏感性验证研究。
Mult Scler Relat Disord. 2020 Jan;37:101458. doi: 10.1016/j.msard.2019.101458. Epub 2019 Oct 18.
3
The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).简短国际认知评估用于多发性硬化症的挪威语翻译版(BICAMS)。
Mult Scler Relat Disord. 2019 Nov;36:101408. doi: 10.1016/j.msard.2019.101408. Epub 2019 Sep 21.
4
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.复发缓解型多发性硬化症中符号数字模式测验(SDMT)和听觉序列加法测验(PASAT)的一年随访研究:比较纵向敏感性评估
BMC Neurol. 2015 Mar 22;15:40. doi: 10.1186/s12883-015-0296-2.
5
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).多发性硬化症简短国际认知评估工具(BICAMS)在爱尔兰多发性硬化症(MS)患者群体中的初步验证。
Mult Scler Relat Disord. 2015 Nov;4(6):521-5. doi: 10.1016/j.msard.2015.07.012. Epub 2015 Aug 7.
6
Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.复发缓解型多发性硬化的皮质异常增厚,与认知障碍的相关性,以及补肾益髓汤对多发性硬化认知功能的影响。
J Tradit Chin Med. 2021 Apr;41(2):316-325.
7
The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.匈牙利 BICAMS 验证队列的 7 年随访结果表明,多发性硬化症患者的认知表现可能会改善。
Neurol Sci. 2024 Jul;45(7):3369-3378. doi: 10.1007/s10072-024-07347-5. Epub 2024 Jan 27.
8
Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.匈牙利复发缓解型多发性硬化症和临床孤立综合征患者认知障碍的患病率。
Mult Scler Relat Disord. 2017 Oct;17:57-62. doi: 10.1016/j.msard.2017.06.017. Epub 2017 Jul 1.
9
Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.临床残疾程度极轻微的复发缓解型多发性硬化症患者的认知障碍
Behav Neurol. 2017;2017:7404289. doi: 10.1155/2017/7404289. Epub 2017 Aug 15.
10
Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.简要国际认知评估用于多发性硬化症的评分与复发缓解型患者特定皮质区域的皮质厚度有关。
Rev Neurol (Paris). 2022 Apr;178(4):326-336. doi: 10.1016/j.neurol.2021.06.014. Epub 2021 Oct 14.

引用本文的文献

1
Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a one-year follow-up study.不同多发性硬化症亚型中的认知障碍、情绪和疲劳:一项为期一年的随访研究。
J Neurol. 2025 May 14;272(6):398. doi: 10.1007/s00415-025-13115-y.
2
Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): A systematic review and meta-analysis.多发性硬化症(MS)患者认知障碍(CI)的患病率:一项系统评价和荟萃分析。
Caspian J Intern Med. 2024 Summer;15(3):392-413. doi: 10.22088/cjim.15.3.392.
3
The Prevalence of Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-analysis.
复发缓解型多发性硬化症中认知障碍的患病率:一项系统评价和荟萃分析。
Neuropsychol Rev. 2024 Apr 8. doi: 10.1007/s11065-024-09640-8.